Background: Tumor heterogeneity is a major obstacle for finding effective treatment of Glioblastoma (GBM). Based on global expression analysis, GBM can be classified into distinct subtypes: Proneural, Neural, Classical and Mesenchymal. The signatures of these different tumor subtypes may reflect the phenotypes of cells giving rise to them. However, the experimental evidence connecting any specific subtype of GBM to particular cells of origin is lacking. In addition, it is unclear how different genetic alterations interact with cells of origin in determining tumor heterogeneity. This issue cannot be addressed by studying end-stage human tumors. Methodology/Principal Findings: To address this issue, we used retroviruses to deliver transformin...
SummaryA central question in glioblastoma multiforme (GBM) research is the identity of the tumor-ini...
Thesis (Ph.D.)--University of Rochester. School of Medicine and Dentistry. Dept. of Biomedical Genet...
High-grade glioma, particularly, glioblastoma, is the most aggressive cancer of the central nervous ...
Tumor heterogeneity is a major obstacle for finding effective treatment of G...
Glioblastoma Multiforme (GBM) is the most common and lethal of human primary central nervous system ...
Glioblastoma Multiforme (GBM) is the most common and lethal of human primary central nervous system ...
The need of reliable syngeneic animal models for gliomas has been addressed in the last decades by r...
The need of reliable syngeneic animal models for gliomas has been addressed in the last decades by r...
SummaryA central question in glioblastoma multiforme (GBM) research is the identity of the tumor-ini...
Brain tumors are thought to originate from stem/progenitor cell populations that acquire specific ge...
Although tumor-propagating cells can be derived from glioblastomas (GBM) of the proneural and mesenc...
Although tumor-propagating cells can be derived from glioblastomas (GBM) of the proneural and mesenc...
Glioblastoma multiforme (GBM) is the most common and lethal form of primary brain tumor that mainly ...
Glioblastoma multiforme (GBM) is the most common and lethal form of primary brain tumor that mainly ...
Glioblastoma multiforme (GBM) is the most common and lethal form of primary brain tumor that mainly ...
SummaryA central question in glioblastoma multiforme (GBM) research is the identity of the tumor-ini...
Thesis (Ph.D.)--University of Rochester. School of Medicine and Dentistry. Dept. of Biomedical Genet...
High-grade glioma, particularly, glioblastoma, is the most aggressive cancer of the central nervous ...
Tumor heterogeneity is a major obstacle for finding effective treatment of G...
Glioblastoma Multiforme (GBM) is the most common and lethal of human primary central nervous system ...
Glioblastoma Multiforme (GBM) is the most common and lethal of human primary central nervous system ...
The need of reliable syngeneic animal models for gliomas has been addressed in the last decades by r...
The need of reliable syngeneic animal models for gliomas has been addressed in the last decades by r...
SummaryA central question in glioblastoma multiforme (GBM) research is the identity of the tumor-ini...
Brain tumors are thought to originate from stem/progenitor cell populations that acquire specific ge...
Although tumor-propagating cells can be derived from glioblastomas (GBM) of the proneural and mesenc...
Although tumor-propagating cells can be derived from glioblastomas (GBM) of the proneural and mesenc...
Glioblastoma multiforme (GBM) is the most common and lethal form of primary brain tumor that mainly ...
Glioblastoma multiforme (GBM) is the most common and lethal form of primary brain tumor that mainly ...
Glioblastoma multiforme (GBM) is the most common and lethal form of primary brain tumor that mainly ...
SummaryA central question in glioblastoma multiforme (GBM) research is the identity of the tumor-ini...
Thesis (Ph.D.)--University of Rochester. School of Medicine and Dentistry. Dept. of Biomedical Genet...
High-grade glioma, particularly, glioblastoma, is the most aggressive cancer of the central nervous ...